Company Quick10K Filing
Emmaus Life Sciences
10-Q 2019-03-31 Filed 2019-05-14
10-K 2018-12-31 Filed 2019-03-21
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-16
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-19
10-Q 2016-03-31 Filed 2016-06-06
10-K 2015-12-31 Filed 2016-05-20
10-K 2015-09-30 Filed 2016-05-20
10-Q 2015-06-30 Filed 2016-05-20
10-Q 2015-03-31 Filed 2015-05-20
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-20
10-K 2013-12-31 Filed 2014-05-08
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-03-29
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-14
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-04-30 Filed 2011-05-13
10-Q 2011-01-31 Filed 2011-03-11
10-K 2010-10-31 Filed 2011-01-31
10-Q 2010-07-31 Filed 2010-09-14
10-Q 2010-04-30 Filed 2010-06-14
10-Q 2010-01-31 Filed 2010-03-17
10-K 2009-10-31 Filed 2010-01-29
8-K 2019-07-09
8-K 2019-07-08
8-K 2019-07-03
8-K 2019-06-12
8-K 2019-05-29
8-K 2019-03-05
8-K 2019-01-04
8-K 2018-12-19
8-K 2018-10-09
8-K 2018-09-27
8-K 2018-09-13
8-K 2018-07-16
8-K 2018-06-13
8-K 2018-03-29
8-K 2018-01-30
8-K 2017-12-29

Emmaus Life Sciences Financials

EMMA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash4326033141623983344031375435,7733,6391,5353,6051,6415563281,5814834723243236,6281,3173,5455,0884,41522,5565,1132,16916,66217,08015,310
Accounts Receivable39781876435280444525352765544315212310261542014271110276851,7021,4151,3511,760
Inventory2822341952152402562031651621682392532592242502682232952193022422521662612713966251,0082,4353,3474,7055,795
PP&E83786055192195196196197201204225227229265267267270270271274275281326359361361376414441454456
Assets3,6773,2162,4824,1723,3153,0842,8843,0933,7939,0346,1143,6165,8203,6582,6642,2073,4472,2841,4771,3451,26321,56212,99315,38648,42433,604123,845113,50273,93584,80674,55570,735
Accounts Payable1,3511,6581,7581,9671,4931,3248369145946551,2181,7524541,1871,5241,4701,7451,3394769528881,2721,6001,7902,9862,6463,6045,186
Long-Term Debt8,1479,43211,30512,41411,49311,49911,46711,55513,13711,72311,98613,07917,42017,71519,12818,89920,68018,07316,69618,88019,94924,30948,72440,40240,31949,99355,17252,168
Liabilities3,7124,6375,4578,43110,71512,44413,52715,34113,87716,30519,95122,86325,25823,61622,96424,32325,99427,31330,04031,69632,93730,84630,55436,96776,17189,490109,555101,986103,22396,35190,44995,363
Stockholders' Equity-35-1,422-2,975-4,260-7,400-9,360-10,643-12,248-10,084-7,271-13,838-19,247-19,438-19,958-20,300-22,116-22,547-25,030-28,563-30,351-31,674-9,284-17,562-21,581-27,748-55,88514,29111,516-29,289-11,545-15,797-24,546
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Revenue981522814510711317890916614485126156153971447727279173621481071641401477812,5714,8825,307
Cost of Revenue4657421293797446248494761906950643713628832189487312962135221141200
Gross Profit5295241251087780463618953867658447814013651904159599212856472,3504,7415,107
R&D3385333715438967807576156964906356057115072572443034655675025853695327561,584379483411396466513
SG&A1,6532,2191,0231,6352,6711,8782,5262,5343,3992,7212,5983,1123,7812,8743,1973,3722,4472,2522,3872,3412,7602,2942,9013,7473,4386,3624,6774,7116,4065,166
Tax0036001320-1852201220200120010
Net Income-1,947-2,913-2,841-2,945-4,195-3,452-3,842-3,363-3,662-3,708-3,245-6,740-7,378-3,726-2,972-3,604-1,655-3,444-4,460-3,142-6,258-7,318-6,495-11,776-17,2672,166-6,097-47,34314,569-14,153
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash Operating-2,450-1,505-1,014-1,794-1,613-2,028-1,436-2,339-1,937-2,677-2,172-2,876-2,218-1,469-1,228-1,235-1,486-2,360-2,071-15,4159,8131,966579-5,91327,563-615-1,665-1,284
Cash Investing-11-1,502-3-200-1-4588-21-2-2-38-10-14,008-40-44-2-31,974-4846,380-16
Cash Financing2,6221,2182,3672,0681,5532,0691,1762,7707,178-65884,9482604251,0021261,4312,2082,06721,650-1,0312999685,23422,616-16,3309,775-492